Peaks of Interest
Agilent (Palo Alto, California) recently announced plans to open a new training center in Shanghai, China.
Agilent to open training center in Shanghai
Agilent (Palo Alto, California) recently announced plans to open a new training center in Shanghai, China. The center will train scientists across the Asia-Pacific region on key measurement technologies used in food safety, environmental testing, petrochemical testing, pharmaceutical testing, and life sciences.
Animal Testing and Preclinical Development
The new training center will be located next to Agilent's R&D and manufacturing center in Shanghai and will serve scientists from the industrial, government, and academic sectors within China and throughout the Asia-Pacific region.
Bruker Daltonics selected by Department of Homeland Security
Bruker Daltonics NBC Detection Corporation (Billerica, Massachusetts) has received a $0.75 million follow-on Phase II contract award from the U.S. Department of Homeland Security for further research and development into the Autonomous Rapid Facility Chemical Agent Monitor (ARFCAM). ARFCAM is intended to be the next generation chemical agent monitor for government facilities.
Thermo Electron completes Kendro acquisition
Thermo Electron (Waltham, Massachuets) has completed its acquisition of Kendro Laboratory Products (Charlotte, North Carolina).
In January, Thermo Electron had signed an agreement to acquire Kendro for $833.5 million. Kendro is a global leader in sample preparation products and services for life science, material science, and drug discovery applications.
Marijn E. Dekkers, president and chief executive officer of Thermo Electron, said, "Thermo is focused on providing total laboratory solutions and services to address our customers' needs, and Kendro's technologies nicely complement our existing portfolio of products and services."
Whatman appoints chief executive
Whatman (Clifton, New Jersey) recently appointed Timothy J. Haines chief executive.
Haines has a broad range of international management experience in the life sciences industry and was chief executive of Astex Technology (Cambridge, U.K.) for five years.
Tom McNally, a non-executive director of Whatman, has taken executive responsibility for R&D, business development, and sales. McNally will continue in this role as long as necessary and will then return to a non-executive position.
Free Poster: NDSRI Risk Assessment and Trace-Level Analysis of N-Nitrosamines
April 25th 2025With increasing concern over genotoxic nitrosamine contaminants, regulatory bodies like the FDA and EMA have introduced strict guidelines following several high-profile drug recalls. This poster showcases a case study where LGC and Waters developed a UPLC/MS/MS method for quantifying trace levels of N-nitroso-sertraline in sertraline using Waters mass spectrometry and LGC reference standards.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
Using the Carcinogenic Potency Categorisation Approach (CPCA) to Classify N-nitrosamine Impurities
April 25th 2025Learn how to manage nitrosamine impurities in pharmaceuticals with our free infographic. Discover how the CPCA approach establishes acceptable intake limits and guides the selection of NDSRI reference samples. Stay compliant and ensure safety with our ISO-accredited standards.
